CAS: 4045-30-1 - 4,4-dimethylpiperidine
Fórmula:C7H15N
InChI:InChI=1S/C7H15N/c1-7(2)3-5-8-6-4-7/h8H,3-6H2,1-2H3
Clave InChI:InChIKey=IECMOFZIMWVOAS-UHFFFAOYSA-N
SMILES:N1CCC(C)(C)CC1
- Sinónimos:
- NSC 107116
- Piperidine, 4,4-Dimethyl-
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4,4-dimethylpiperidine REF: IN-DA00C74UCAS: 4045-30-1 | 95% | A consultar | Mar 19 Nov 24 |
 | 4,4-Dimethylpiperidine REF: 54-OR17132CAS: 4045-30-1 | 98% | 209,00 €~605,00 € | Mar 26 Nov 24 |
 | 4,4-Dimethyl-piperidine REF: 10-F075595CAS: 4045-30-1 | 95.0% | A consultar | Vie 29 Nov 24 |
 | 4,4-Dimethylpiperidine REF: 3D-EAA04530CAS: 4045-30-1 | Min. 95% | A consultar | Jue 02 Ene 25 |
4,4-dimethylpiperidine
CAS:4045-30-1
Fórmula:
C7H15N
Pureza:
95%
Forma y color:
Liquid
Peso molecular:
113.2007
Ref: IN-DA00C74U
| 1g | 113,00 € | ||
| 5g | 245,00 € | ||
| 10g | 570,00 € | ||
| 25g | A consultar | ||
| 50mg | 51,00 € | ||
| 250mg | 49,00 € | ||
| 500mg | 71,00 € |
Entrega estimada en Estados Unidos, el Martes 19 de Noviembre de 2024
4,4-Dimethylpiperidine
CAS:4045-30-1
Fórmula:
C7H15N
Pureza:
98%
Forma y color:
colourless liquid
Peso molecular:
113.20g/mol
Ref: 54-OR17132
| 1g | 209,00 € | ||
| 5g | 605,00 € |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
4,4-Dimethyl-piperidine
CAS:4045-30-1
Pureza:
95.0%
Forma y color:
Liquid
Peso molecular:
113.2040023803711
Ref: 10-F075595
| 1g | 114,00 € | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 25g | A consultar | ||
| 50mg | 41,00 € | ||
| 100mg | 50,00 € | ||
| 250mg | 69,00 € | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 29 de Noviembre de 2024
4,4-Dimethylpiperidine
CAS:4045-30-1
4,4-Dimethylpiperidine is a chemical compound that is an asymmetric synthesis product of the reaction between …
Fórmula:
C7H15N
Pureza:
Min. 95%
Peso molecular:
113.2 g/mol
Ref: 3D-EAA04530
| 250mg | 229,00 € | ||
| 2500mg | 894,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
